Cyber Monday saleUp to 70% OFF
AAA

THERAVET

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

ALVET chart


Full chart

Key stats


Market capitalization
‪278.40 K‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.4698 EUR
Net income (FY)
‪−1.57 M‬ EUR
Revenue (FY)
‪117.84 K‬ EUR
Shares float
—
Beta (1Y)
0.39

Employees


Employees (FY)
7
Change (1Y)
−4 −36.36%
Revenue / Employee (1Y)
‪18.58 K‬ EUR
Net income / Employee (1Y)
‪−247.66 K‬ EUR

About THERAVET


Sector
Commercial Services
Industry
Miscellaneous Commercial Services
CEO
Enrico Jose Adolfo Bastianelli
Website
thera.vet
Headquarters
Gosselies
Founded
2017
ISIN
BE0974387194
FIGI
BBG01175J220
TheraVet SA is a veterinary biotech company, which specializes in the development and production of treatments for osteoarticular diseases in cats, dogs, and horses. Its products include Biocera-Vet and Visco-Vet. The company was founded by Enrico Jose Adolfo Bastianelli on November 21, 2017 and is headquartered in Gosselies, Belgium.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

ALVET news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ALVET is 0.1240 EUR — it has increased by 45.51% in the past 24 hours. Watch THERAVET stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange THERAVET stocks are traded under the ticker ALVET.
ALVET stock has risen by 62.14% compared to the previous week, the month change is a 4.13% rise, over the last year THERAVET has showed a −91.62% decrease.
ALVET reached its all-time high on Jun 21, 2021 with the price of 8.5600 EUR, and its all-time low was 0.0632 EUR and was reached on Nov 26, 2024. View more price dynamics on ALVET chart.
See other stocks reaching their highest and lowest prices.
ALVET stock is 86.19% volatile and has beta coefficient of 0.39. Track THERAVET stock price on the chart and check out the list of the most volatile stocks — is THERAVET there?
Yes, you can track THERAVET financials in yearly and quarterly reports right on TradingView.
ALVET net income for the last half-year is ‪−848.70 K‬ EUR, while the previous report showed ‪−665.55 K‬ EUR of net income which accounts for −27.52% change. Track more THERAVET financial stats to get the full picture.
No, ALVET doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 3, 2024, the company has 7.00 employees. See our rating of the largest employees — is THERAVET on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. THERAVET EBITDA is ‪−1.30 M‬ EUR, and current EBITDA margin is −942.90%. See more stats in THERAVET financial statements.
Like other stocks, ALVET shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade THERAVET stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So THERAVET technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating THERAVET stock shows the sell signal. See more of THERAVET technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.